Revenue - S2Medical AB (publ) (STO:S2M) - Alpha Spread
S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.024 SEK Market Closed
Market Cap: 6.4m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

S2Medical AB (publ)
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

S2Medical AB (publ)
Revenue Peer Comparison

Comparables:
O
OSSD
XVIVO
D
DOXA
BACTI B
V
VIMIAN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
S2Medical AB (publ)
STO:S2M
Revenue
kr10.6m
CAGR 3-Years
-3%
CAGR 5-Years
45%
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Revenue
kr112.2m
CAGR 3-Years
65%
CAGR 5-Years
53%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Revenue
kr698.7m
CAGR 3-Years
47%
CAGR 5-Years
28%
CAGR 10-Years
25%
D
Doxa AB
STO:DOXA
Revenue
kr16.8m
CAGR 3-Years
11%
CAGR 5-Years
-11%
CAGR 10-Years
9%
Bactiguard Holding AB
STO:BACTI B
Revenue
kr223.2m
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Revenue
€344.6m
CAGR 3-Years
38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is S2Medical AB (publ)'s Revenue?
Revenue
10.6m SEK

Based on the financial report for Jun 30, 2024, S2Medical AB (publ)'s Revenue amounts to 10.6m SEK.

What is S2Medical AB (publ)'s Revenue growth rate?
Revenue CAGR 5Y
45%

Over the last year, the Revenue growth was 96%. The average annual Revenue growth rates for S2Medical AB (publ) have been -3% over the past three years , 45% over the past five years .

Back to Top